Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC
University of Pittsburgh
University of Pittsburgh
Memorial Sloan Kettering Cancer Center
Incyte Corporation
Shanghai Pulmonary Hospital, Shanghai, China
University Hospital Southampton NHS Foundation Trust
Faeth Therapeutics
Shanghai Pulmonary Hospital, Shanghai, China
Rain Oncology Inc
Big Ten Cancer Research Consortium
AbbVie
The Netherlands Cancer Institute
Clovis Oncology, Inc.
Guizhou Medical University
Dana-Farber Cancer Institute
Seoul National University Hospital
AIO-Studien-gGmbH
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Sanofi
Memorial Sloan Kettering Cancer Center
SCRI Development Innovations, LLC
Chonnam National University Hospital
Sanofi
Poniard Pharmaceuticals
Genentech, Inc.